Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|May 27, 2023
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate CancerLevi Groen, Iris Kloots, David Englert, et al.
Genes, Chromosomes & Cancer|April 19, 2005
Identification of androgen-responsive genes that are alternatively regulated in androgen-dependent and androgen-independent rat prostate tumorsRolph Pfundt, Frank Smit, Corine Jansen, et al.
The Prostate|August 1, 2009
In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissueNatalia Guzmán-Ramírez, Maureen Völler, Antoinette Wetterwald, et al.
Urology Practice|June 15, 2023
Urinary Molecular Biomarker Test Impacts Prostate Biopsy Decision Making in Clinical PracticeNeal Shore, Jason Hafron, Timothy Langford, et al.
The Journal of Urology|April 27, 2019
Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate BiopsyAlexander Haese, Geert Trooskens, Sandra Steyaert, et al.
European Urology|April 28, 2015
Genomic Predictors of Outcome in Prostate CancerPeter J Boström, Anders S Bjartell, James W F Catto, et al.
The Prostate|September 16, 2011
Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancerPaula Vainio, Maija Wolf, Henrik Edgren, et al.
Cancer Research|November 3, 2006
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogrammingKristiina Iljin, Maija Wolf, Henrik Edgren, et al.
Frontiers in Oncology|October 30, 2025
Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer modelsArjanneke F van de Merbel, Maaike H van der Mark, Tilly Aalders, et al.
European Urology|August 30, 2011
Contemporary role of prostate cancer antigen 3 in the management of prostate cancerMarco Auprich, Anders Bjartell, Felix K-H Chun, et al.
Pageof 4